Pompeyo Viciana

Instituto de Biomedicina de Sevilla — Spain

Medicine · Health Sciences

40h-index7.0kcitations193works5.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(99), HIV Research and Treatment(96), HIV/AIDS Research and Interventions(78), Hepatitis C virus research(29), HIV-related health complications and treatments(28)

Publications188 total

Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size
JCI Insight·2024· 5 citedOpen Access
Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program.
PubMed·2022· 3 cited
Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program
Diseases of the Colon & Rectum·2021· 14 cited
Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: Early results of a phase I/II clinical trial
Stem Cells Translational Medicine·2020· 13 citedOpen Access
Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study
Journal of the International AIDS Society·2020· 2 citedOpen Access
Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort
AIDS Research and Human Retroviruses·2020
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV·2020· 68 citedOpen Access
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study
AIDS Research and Therapy·2020· 1 citedOpen Access
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus
Antimicrobial Agents and Chemotherapy·2020· 11 citedOpen Access
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
Journal of Antimicrobial Chemotherapy·2019· 9 cited
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
AIDS Research and Human Retroviruses·2019· 13 citedOpen Access
Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients
PLoS ONE·2019· 16 citedOpen Access
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
The Lancet·2019· 967 citedOpen Access
Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions
Vaccine·2019· 7 cited
Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice
JAIDS Journal of Acquired Immune Deficiency Syndromes·2019· 10 cited
VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients
Journal of Clinical Medicine·2019· 11 citedOpen Access
High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities
Clinical Infectious Diseases·2019· 11 cited
High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
Papillomavirus Research·2019· 19 citedOpen Access
Incidencia de enfermedad pulmonar obstructiva crónica en pacientes con el virus de la inmunodeficiencia humana: análisis post-hoc del estudio viva
Revista española de patología torácica·2019
Two-drug regimen of dolutegravir plus lamivudine (DTG+3TC) is noninferior to dolutegravir plus tenofovir/emtricitabine (DTG+TDF/FTC) at 48 weeks in antiretroviral treatment-naive adults with HIV-1 infection: subgroup analyses in the GEMINI studies
Journal of Infection and Public Health·2019· 1 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Santiago Moreno(15), Félix Gutiérrez(13), Julia del Amo(13), José Ramón Blanco(11), Luís F. López‐Cortés(10), José Antonio Iribarren(10), Manuel Leal(10), Francesc Vidal(10), Jorge del Romero(9), Mar Masiá(8), Juan Berenguer(8), Esteban Ribera(8), Bonaventura Clotet(7), Rafael Rubio(7), Peré Domingo(6), Ezequiel Ruíz-Mateos(6), Jerónimo Pachón(5), Ignacio de los Santos(5), Inmaculada Jarrín(5), Montserrat Torres(5)